Timmer-Bosscha H - Search Results

1

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model.

van der Bilt AR, Terwisscha van Scheltinga AG, Timmer-Bosscha H, Schröder CP, Pot L, Kosterink JG, van der Zee AG, Lub-de Hooge MN, de Jong S, de Vries EG, Reyners AK. van der Bilt AR, et al. Clin Cancer Res. 2012 Nov 15;18(22):6306-14. doi: 10.1158/1078-0432.CCR-12-0406. Epub 2012 Sep 26. Clin Cancer Res. 2012. PMID: 23014526

2

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.

Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE, Mulder NH. Smit EF, et al. Int J Cancer. 1992 Apr 22;51(1):72-8. doi: 10.1002/ijc.2910510115. Int J Cancer. 1992. PMID: 1314232

3

Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.

Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG. Meijer C, et al. Cancer Res. 1992 Dec 15;52(24):6885-9. Cancer Res. 1992. PMID: 1458477

4

Modulation of cis-diamminedichloroplatinum(II) resistance: a review.

Timmer-Bosscha H, Mulder NH, de Vries EG. Timmer-Bosscha H, et al. Br J Cancer. 1992 Aug;66(2):227-38. doi: 10.1038/bjc.1992.249. Br J Cancer. 1992. PMID: 1503895 Free PMC article. Review.

5

Combined in vitro modulation of adriamycin resistance.

Meijer C, Mulder NH, Timmer-Bosscha H, Peters WH, de Vries EG. Meijer C, et al. Int J Cancer. 1991 Oct 21;49(4):582-6. doi: 10.1002/ijc.2910490419. Int J Cancer. 1991. PMID: 1680815

6

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.

Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG. Timmer-Bosscha H, et al. J Natl Cancer Inst. 1989 Jul 19;81(14):1069-75. doi: 10.1093/jnci/81.14.1069. J Natl Cancer Inst. 1989. PMID: 2544740

7

Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.

de Vries EG, Meijer C, Timmer-Bosscha H, Berendsen HH, de Leij L, Scheper RJ, Mulder NH. de Vries EG, et al. Cancer Res. 1989 Aug 1;49(15):4175-8. Cancer Res. 1989. PMID: 2545337

8

Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell lines.

Zijlstra JG, de Vries EG, Muskiet FA, Martini IA, Timmer-Bosscha H, Mulder NH. Zijlstra JG, et al. Int J Cancer. 1987 Dec 15;40(6):850-6. doi: 10.1002/ijc.2910400625. Int J Cancer. 1987. PMID: 2826341

9

Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay.

de Jong S, Zijlstra JG, Timmer-Bosscha H, Mulder NH, de Vries EG. de Jong S, et al. Int J Cancer. 1986 Apr 15;37(4):557-61. doi: 10.1002/ijc.2910370414. Int J Cancer. 1986. PMID: 3007375

10

Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.

Meijer C, Mulder NH, Timmer-Bosscha H, Zijlstra JG, de Vries EG. Meijer C, et al. Cancer Res. 1987 Sep 1;47(17):4613-7. Cancer Res. 1987. PMID: 3040227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters